Please login to the form below

Not currently logged in
Email:
Password:

New hires for Wave

Med ed agency adds three new team members
Wave, Charlotte WilkinsonWave, James KeaneWave, Philippa Hatch

Charlotte Wilkinson, James Keane, Philippa Hatch

UK-based medical education company Wave has appointed three new members of staff.

Charlotte Wilkinson (top left) joins as programme manager and James Keane (top centre) and Philippa Hatch (top right) as senior programme executives.

Wilkinson comes from a background of managing communication programmes in the healthcare sector and for the Royal Society of Chemistry.

Hatch has experience in both programme management and business development within healthcare communication agencies. Keane joins Wave from a publishing background, having worked as a production editor on a number of scientific journals.

“We are delighted that Charlotte, Philippa and James have joined us as they each complement the skills base we have within Wave,” said Wave co-owner and director Rod Ball.

“These appointments reflect the continuing growth of our business as we expand our European and international work”.

Founded in April 2001, Amersham-based Wave partners with market access, patient programme and PR specialists to provide integrated communications.

The agency works with pharma companies, providing services ranging from advocacy management to NHS policy and local initiatives.

28th May 2014

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics